Sodium tanshinone IIA sulfonate ameliorates neointima by protecting endothelial progenitor cells in diabetic mice

Sodium tanshinone IIA sulfonate ameliorates neointima by protecting endothelial progenitor cells in diabetic mice

Abstract Background Endothelial progenitor cells (EPCs) transplantation is one of the effective therapies for neointima associated with endothelial injury. Diabetes impairs the function of EPCs and cumbers neointima prevention of EPC transplantation with an ambiguous mechanism. Sodium Tanshinone IIA...

Full description

Bibliographic Details
Main Authors:	Yan-Yan Heng, Hui-Juan Shang, Xia-ze Zhang, Wei Wei
Format:	Article
Language:	English
Published:	BMC 2023-09-01
Series:	BMC Cardiovascular Disorders
Subjects:	Endothelial progenitor cell Sodium tanshinone IIA sulfonate NLRP3 inflammasome Catalase Neointima
Online Access:	https://doi.org/10.1186/s12872-023-03485-4

Similar Items

Tanshinone IIA ameliorates acute lung injury by inhibition of the NLRP3 inflammasome
by: Chen Tianyu, et al.
Published: (2019-01-01)

Protective effects of tanshinone IIA sodium sulfonate on ischemia-reperfusion-induced myocardial injury in rats
by: Yun Pan, et al.
Published: (2017-03-01)

Exploration of Multiple Signaling Pathways Through Which Sodium Tanshinone IIA Sulfonate Attenuates Pathologic Remodeling Experimental Infarction
by: Shuai Mao, et al.
Published: (2019-07-01)

Efficacy and Safety of Sodium Tanshinone IIA Sulfonate Injection on Hypertensive Nephropathy: A Systematic Review and Meta-Analysis
by: Junyao Xu, et al.
Published: (2019-12-01)

Preparation and characterisation of solid dispersions of tanshinone IIA, cryptotanshinone and total tanshinones
by: Xifeng Zhai, et al.
Published: (2017-01-01)

Sodium Tanshinone IIA Sulfonate Inhibits Vascular Endothelial Cell Pyroptosis via the AMPK Signaling Pathway in Atherosclerosis
by: Zhu J, et al.
Published: (2022-11-01)

Mechanism Study of the Protective Effects of Sodium Tanshinone IIA Sulfonate Against Atorvastatin-Induced Cerebral Hemorrhage in Zebrafish: Transcriptome Analysis
by: Zhong-Yan Zhou, et al.
Published: (2020-10-01)

Evaluation of Tanshinone IIA Developmental Toxicity in Zebrafish Embryos
by: Tao Wang, et al.
Published: (2017-04-01)

A systematic review and meta-analysis on sodium tanshinone IIA sulfonate injection for the adjunctive therapy of pulmonary heart disease
by: Huikai Shao, et al.
Published: (2024-04-01)

Sodium Tanshinone IIA Sulfonate as a Potent IDO1/TDO2 Dual Inhibitor Enhances Anti-PD1 Therapy for Colorectal Cancer in Mice
by: Rongjie Zhang, et al.
Published: (2022-04-01)

Renoprotective Effects of Tanshinone IIA: A Literature Review
by: Zhengtao Chen, et al.
Published: (2023-02-01)

Tanshinone IIA inactivates Akt and induces caspase-dependent death in cervical cancer cells via the mitochondrial pathway
by: Hu Li, et al.
Published: (2015-06-01)

NGHIÊN CỨU PHƯƠNG PHÁP PHÂN LẬP TANSHINONE IIA TỪ ĐAN SÂM LÀM CHẤT ĐỐI CHIẾU
by: Trịnh Thị Điệp, et al.
Published: (2015-03-01)

Metabolism of Tanshinone IIA, Cryptotanshinone and Tanshinone I from Radix Salvia Miltiorrhiza in Zebrafish
by: Bing Wang, et al.
Published: (2012-07-01)

Tanshinone IIA alleviates atherosclerosis in LDLR−/− mice by regulating efferocytosis of macrophages
by: Jiarou Wang, et al.
Published: (2023-10-01)

Sodium Tanshinone IIA Sulfonate Decreases Cigarette Smoke-Induced Inflammation and Oxidative Stress via Blocking the Activation of MAPK/HIF-1α Signaling Pathway
by: Ruijuan Guan, et al.
Published: (2018-05-01)

Effects of sodium tanshinone IIA sulfonate injection on inflammatory factors and vascular endothelial function in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A systematic review and meta-analysis of randomized clinical trials
by: Zunqi Kan, et al.
Published: (2023-03-01)

Tanshinone IIA protects intestinal epithelial cells from deoxynivalenol-induced pyroptosis
by: Cong Zhang, et al.
Published: (2024-01-01)

Tanshinone IIA alleviates chondrocyte apoptosis and extracellular matrix degeneration by inhibiting ferroptosis
by: Xu Jin, et al.
Published: (2023-08-01)

Tanshinone IIA: A Review of its Anticancer Effects
by: Zhong‐ying Fang, et al.
Published: (2021-01-01)

Multifunctional icariin and tanshinone IIA co-delivery liposomes with potential application for Alzheimer’s disease
by: Jiao Wang, et al.
Published: (2022-12-01)

Tanshinone IIA prevents platelet activation and down-regulates CD36 and MKK4/JNK2 signaling pathway
by: Hua Wang, et al.
Published: (2020-02-01)

Pharmacological Activity and Mechanism of Tanshinone IIA in Related Diseases
by: Guo R, et al.
Published: (2020-11-01)

Tanshinone IIA enhances the ovarian reserve and attenuates ovarian oxidative stress in aged mice
by: Lin Bai, et al.
Published: (2022-07-01)

Possible mechanisms of treatment for spinal cord injury repair with tanshinone IIA
by: Zhiwei Jia, et al.
Published: (2023-09-01)

Therapeutic and pharmacological potential of Tanshinones against lung cancer: A systematic review
by: Syed Sahajada Mahafujul Alam, et al.
Published: (2022-02-01)

Improvement of Bioavailability and Dissolution of Tanshinone IIA by Encapsulating it with Hydroxypropyl-β-Cyclodextrin
by: Jie Yu, et al.
Published: (2020-09-01)

Tanshinone IIA suppresses burning incense-induced oxidative stress and inflammatory pathways in astrocytes
by: Miao-Ching Chi, et al.
Published: (2023-06-01)

Tanshinone IIA Attenuates Contrast-Induced Nephropathy via Nrf2 Activation in Rats
by: Rulian Liang, et al.
Published: (2018-05-01)

Recent Research Progress (2015–2021) and Perspectives on the Pharmacological Effects and Mechanisms of Tanshinone IIA
by: Chenhui Zhong, et al.
Published: (2021-11-01)

Tanshinone IIA promotes vascular normalization and boosts Sorafenib’s anti-hepatoma activity via modulating the PI3K-AKT pathway
by: Chengdong Qin, et al.
Published: (2023-06-01)

Tanshinone IIA Protects Against Cerebral Ischemia Reperfusion Injury by Regulating Microglial Activation and Polarization via NF-κB Pathway
by: Zhibing Song, et al.
Published: (2021-04-01)

Tanshinone IIA Has a Potential Therapeutic Effect on Kawasaki Disease and Suppresses Megakaryocytes in Rabbits With Immune Vasculitis
by: Hui Chen, et al.
Published: (2022-04-01)

Potential pharmacological mechanisms of tanshinone IIA in the treatment of human neuroblastoma based on network pharmacological and molecular docking Technology
by: Ning Tang, et al.
Published: (2024-03-01)

Analysis of tanshinone IIA induced cellular apoptosis in leukemia cells by genome-wide expression profiling
by: Liu Chang, et al.
Published: (2012-01-01)

Tanshinone IIA inhibits cardiomyocyte pyroptosis through TLR4/NF-κB p65 pathway after acute myocardial infarction
by: Ruoning Chai, et al.
Published: (2023-09-01)

Tanshinone IIA ameliorates dextran sulfate sodium-induced inflammatory bowel disease via the pregnane X receptor
by: Zhang X, et al.
Published: (2015-12-01)

Neuroprotective effect of tanshinone IIA-modified mesenchymal stem cells in a lipopolysaccharide-induced neuroinflammation model
by: Jingjing Wu, et al.
Published: (2024-04-01)

The therapeutic effect of tanshinone IIA in mouse astrocytes after treatment with Angiostrongylus cantonensis fifth-stage larval excretory-secretory products
by: Kuang-Yao Chen, et al.
Published: (2023-08-01)

Tanshinone IIA inhibits metastasis after palliative resection of hepatocellular carcinoma and prolongs survival in part via vascular normalization
by: Wang Wen-Quan, et al.
Published: (2012-11-01)